Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

Abstract:

:There is now strong experimental evidence that tissue factor pathway inhibitor (TFPI) is a critical inhibitor to modulate tissue factor-induced coagulation, but the role of TFPI as a risk factor for thrombosis is yet to be to be determined. This study investigated the role of low TFPI levels for the development of deep-vein thrombosis (DVT). We determined TFPI activity and TFPI-free and total antigen levels in the subjects enrolled in the Leiden Thrombophilia Study, which is a large population-based case-control study of 474 patients and 474 controls. The odds ratio (OR) for DVT in subjects who had TFPI-free antigen levels below the 10th percentile, as compared with those who had TFPI-free antigen levels above this cutoff, was 1.7 (95% confidence interval [CI], 1.1-2.6). The ORs for low TFPI activity and low total antigen were also mildly increased. When the 5th percentile was used as a cutoff, the ORs were 2.1 (95% CI, 1.1-4.1) for both TFPI-free antigen and TFPI total antigen. Exogenous female hormones had a profound lowering effect on TFPI levels, with lower levels in oral contraceptive users than in premenopausal nonusers, who had lower levels than men and postmenopausal women. These results indicate that low levels of TFPI, especially low TFPI-free and total antigen in plasma, constitute a risk factor for DVT.

journal_name

Blood

journal_title

Blood

authors

Dahm A,Van Hylckama Vlieg A,Bendz B,Rosendaal F,Bertina RM,Sandset PM

doi

10.1182/blood-2002-10-3188

subject

Has Abstract

pub_date

2003-06-01 00:00:00

pages

4387-92

issue

11

eissn

0006-4971

issn

1528-0020

pii

2002-10-3188

journal_volume

101

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells.

    abstract::Angiotensin I-converting enzyme (ACE) inhibitors can affect hematopoiesis by several mechanisms including inhibition of angiotensin II formation and increasing plasma concentrations of AcSDKP (acetyl-N-Ser-Asp-Lys-Pro), an ACE substrate and a negative regulator of hematopoiesis. We tested whether ACE inhibition could ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3828

    authors: Charrier S,Michaud A,Badaoui S,Giroux S,Ezan E,Sainteny F,Corvol P,Vainchenker W

    更新日期:2004-08-15 00:00:00

  • Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.

    abstract::Fibrin deposition and platelet thrombus dimensions on subendothelium were studied in four groups of patients with coagulation factor deficiencies. Five patients with factor VIII deficiency (APTT 120 +/- 8 sec) and three patients with factor IX deficiency (APTT 125 +/- 11 sec) were severe bleeders, whereas four patient...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weiss HJ,Turitto VT,Vicic WJ,Baumgartner HR

    更新日期:1984-05-01 00:00:00

  • CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes.

    abstract::Evidence is presented showing that a protein tyrosine phosphatase different from CD45 is present on the membrane of human hematopoietic cells. The molecule recognized by the monoclonal antibody 143-41, which has been classified as CD148 in the VI International Workshop on Leukocyte Differentiation Antigens, was immuno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de la Fuente-García MA,Nicolás JM,Freed JH,Palou E,Thomas AP,Vilella R,Vives J,Gayá A

    更新日期:1998-04-15 00:00:00

  • Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.

    abstract::Many researchers have speculated that the clinical progression from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) is driven by defects in dendritic cell (DC) function. However, evidence supporting this assumption is controversial, and no mechanism for the putative DC dysfunction ha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-623975

    authors: Leone P,Berardi S,Frassanito MA,Ria R,De Re V,Cicco S,Battaglia S,Ditonno P,Dammacco F,Vacca A,Racanelli V

    更新日期:2015-09-17 00:00:00

  • Arachidonic acid mediates interferon-gamma-induced sphingomyelin hydrolysis and monocytic marker expression in HL-60 cell line.

    abstract::The biochemical signaling mechanisms involved in transducing the effects of interferon-gamma (IFN-gamma) on human leukemia-derived HL-60 cell differentiation are not completely understood. Recent studies established the existence of a sphingomyelin (SM) cycle that operates in response to the action of IFN-gamma on HL-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Visnjić D,Batinić D,Banfić H

    更新日期:1997-01-01 00:00:00

  • CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.

    abstract::Intravenous infusion of autologous chronic lymphocytic leukemia (CLL) cells transduced with an adenovirus encoding CD40-ligand (CD154) caused rapid reductions in leukemia-cell counts and lymphnode size. We hypothesized that CD40-ligation via CD154 sensitized CLL cells to death-receptor-mediated apoptosis. We found tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-04-017749

    authors: Dicker F,Kater AP,Prada CE,Fukuda T,Castro JE,Sun G,Wang JY,Kipps TJ

    更新日期:2006-11-15 00:00:00

  • Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis.

    abstract::Transforming growth factor-β1 (TGF-β1) is the most important cytokine involved in the promotion of myelofibrosis. Mechanisms leading to its local activation in the bone marrow environment remain unclear. As a recent study has highlighted the role of thrombospondin-1 (TSP-1) in platelet-derived TGF-β1 activation, we in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-294447

    authors: Evrard S,Bluteau O,Tulliez M,Rameau P,Gonin P,Zetterberg E,Palmblad J,Bonnefoy A,Villeval JL,Vainchenker W,Giraudier S,Wagner-Ballon O

    更新日期:2011-01-06 00:00:00

  • Bone marrow transplantation for Fanconi anemia.

    abstract::Fanconi anemia is a genetic disorder associated with diverse congenital abnormalities, progressive bone marrow failure, and increased risk of leukemia and other cancers. Affected persons often die before 30 years of age. Bone marrow transplantation is an effective treatment, but there are few data regarding factors as...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gluckman E,Auerbach AD,Horowitz MM,Sobocinski KA,Ash RC,Bortin MM,Butturini A,Camitta BM,Champlin RE,Friedrich W,Good RA,Gordon-Smith EC,Harris RE,Klein JP,Ortega JJ,Pasquini R,Ramsay NK,Speck B,Vowels MR,Zhang MJ,

    更新日期:1995-10-01 00:00:00

  • U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

    abstract::Small nuclear U1-RNAs (snRNAs), the spliceosome components selectively recognizing donor splice sites (5'ss), were engineered to restore correct mRNA processing in a cellular model of severe coagulation factor VII (FVII) deficiency, caused by the IVS7 9726 + 5g/a change. Three U1-snRNAs, complementary to the mutated 5...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-10-117440

    authors: Pinotti M,Rizzotto L,Balestra D,Lewandowska MA,Cavallari N,Marchetti G,Bernardi F,Pagani F

    更新日期:2008-03-01 00:00:00

  • Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis.

    abstract::To study the role of the stress-induced "readthrough" acetylcholinesterase splice variant, AChE-R, in thrombopoiesis, we used transgenic mice overexpressing human AChE-R (TgR). Increased AChE hydrolytic activity in the peripheral blood of TgR mice was associated with increased thrombopoietin levels and platelet counts...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-08-3240

    authors: Pick M,Perry C,Lapidot T,Guimaraes-Sternberg C,Naparstek E,Deutsch V,Soreq H

    更新日期:2006-04-15 00:00:00

  • The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma.

    abstract::CD30 is a promising target for antibody-based immunotherapy of Hodgkin lymphoma (HL) and anaplastic large cell lymphoma. To overcome the limitations from currently available murine anti-CD30 monoclonal antibodies (mAbs), a new fully human anti-CD30 antibody was generated. Binding properties were evaluated by recombina...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0515

    authors: Borchmann P,Treml JF,Hansen H,Gottstein C,Schnell R,Staak O,Zhang HF,Davis T,Keler T,Diehl V,Graziano RF,Engert A

    更新日期:2003-11-15 00:00:00

  • Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells.

    abstract::Transcriptional control has been identified as a key mechanism regulating the formation and subsequent behavior of hematopoietic stem cells. We have used a comparative genomics approach to identify transcriptional regulatory elements of the LMO2 gene, a transcriptional cofactor originally identified through its involv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4755

    authors: Landry JR,Kinston S,Knezevic K,Donaldson IJ,Green AR,Göttgens B

    更新日期:2005-10-15 00:00:00

  • Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

    abstract::Hematide is an investigational pegylated synthetic peptide that stimulates erythropoiesis in animal models and is being developed for the treatment of anemia associated with chronic renal failure and cancer. This study evaluated the safety and pharmacodynamics of single, intravenous doses (0.025, 0.05, and 0.1 mg/kg) ...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2006-04-015818

    authors: Stead RB,Lambert J,Wessels D,Iwashita JS,Leuther KK,Woodburn KW,Schatz PJ,Okamoto DM,Naso R,Duliege AM

    更新日期:2006-09-15 00:00:00

  • Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

    abstract::Neutrophil gelatinase-associated lipocalin (NGAL) is a novel 25-kD protein of human neutrophils, that is in part covalently complexed with neutrophil gelatinase. However, both NGAL and gelatinase exist mainly in forms not associated with each other. An explanation for this phenomenon might be that the unassociated pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kjeldsen L,Bainton DF,Sengeløv H,Borregaard N

    更新日期:1994-02-01 00:00:00

  • Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.

    abstract::Intracellular protein transport in endothelial cells is selectively inhibited by homocysteine, a thiol amino acid associated with both thrombosis and atherosclerosis. In a previous study, homocysteine decreased cell surface expression of the surface transmembrane glycoprotein thrombomodulin without decreasing secretio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lentz SR,Sadler JE

    更新日期:1993-02-01 00:00:00

  • Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders.

    abstract::In this study we investigated telomere restriction fragment (TRF) length in a panel of mature B-cell lymphoproliferative disorders (MBCLDs) and correlated this parameter with histology and histopathogenesis in relation to the germinal center (GC). We assessed 123 MBCLD samples containing 80% or more tumor cells. TRF l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4412

    authors: Ladetto M,Compagno M,Ricca I,Pagano M,Rocci A,Astolfi M,Drandi D,di Celle PF,Dell'Aquila M,Mantoan B,Vallet S,Pagliano G,De Marco F,Francese R,Santo L,Cuttica A,Marinone C,Boccadoro M,Tarella C

    更新日期:2004-06-15 00:00:00

  • Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

    abstract::Recent population-based studies demonstrate an increased fracture risk with monoclonal gammopathy of undetermined significance (MGUS). The etiology of this increased risk remains unclear, however, because areal bone mineral density (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-351437

    authors: Ng AC,Khosla S,Charatcharoenwitthaya N,Kumar SK,Achenbach SJ,Holets MF,McCready LK,Melton LJ 3rd,Kyle RA,Rajkumar SV,Drake MT

    更新日期:2011-12-15 00:00:00

  • Induction of an embryonic globin gene promoter by short-chain fatty acids.

    abstract::Short-chain fatty acids (SCFAs) and dimethyl sulfoxide (DMSO) induce adult erythroid differentiation in murine erythroleukemia (MEL) cells, but only SCFAs concurrently up-regulate expression from the endogenous embryonic globin gene epsilony. The epsilony promoter, linked to a reporter gene and stably transfected into...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3766

    authors: Dempsey NJ,Ojalvo LS,Wu DW,Little JA

    更新日期:2003-12-01 00:00:00

  • Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.

    abstract::Chronic myelocytic leukemia (CML) is a common neoplasm of hematopoietic pluripotent stem cells. Although the evolution from chronic phase to blast crisis (BC) in CML patients is an inevitable clinical feature, little is understood about the mechanisms responsible for the transformation. We have previously performed al...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Morosetti R,Spira S,Lee S,Ben-Yehuda D,Schiller G,Landolfi R,Mizoguchi H,Koeffler HP

    更新日期:1998-11-01 00:00:00

  • Localization of thrombospondin in clots formed in situ.

    abstract::Thrombospondin is a principal glycoprotein secreted by thrombin-stimulated platelets and has known affinities for fibrinogen and fibrin. We studied the distribution of thrombospondin in clots formed in situ on Formvar-coated coverslips at 37 degrees C for intervals up to 17 hours. The distributions of three other majo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murphy-Ullrich JE,Mosher DF

    更新日期:1985-11-01 00:00:00

  • Hemopoietic lineage commitment decisions: in vivo evidence from a transgenic mouse model harboring micro LCR-betapro-LacZ as a transgene.

    abstract::A substantial body of published data suggests activation of lineage-specific genes in multipotential hemopoietic cells before their unilineage commitment. Because the behavior and plasticity of cells isolated in vitro away from microenvironmental constraints exercised in vivo may be altered, one wonders whether simila...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Papayannopoulou T,Priestley GV,Rohde A,Peterson KR,Nakamoto B

    更新日期:2000-02-15 00:00:00

  • Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60.

    abstract::Plasma fibronectin (Fn) induces phagocytosis of C3b-opsonized sheep erythrocytes (EC3b) by human peripheral blood monocytes. However, Fn does not induce erythrophagocytosis of EC3b by human polymorphonuclear leukocytes (PMN), unless the PMN have been exposed to C5a or N-formyl-methionyl-leucyl-phenylalanine. Because o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pommier CG,O'Shea J,Chused T,Takahashi T,Ochoa M,Nutman TB,Bianco C,Brown EJ

    更新日期:1984-10-01 00:00:00

  • STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.

    abstract::The tumorigenicity of most cases of ALK-positive anaplastic large-cell lymphoma (ALK+ ALCL) is driven by the oncogenic fusion protein NPM-ALK in a STAT3-dependent manner. Because it has been shown that STAT3 can be inhibited by STAT1 in some experimental models, we hypothesized that the STAT1 signaling pathway is defe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-603738

    authors: Wu C,Molavi O,Zhang H,Gupta N,Alshareef A,Bone KM,Gopal K,Wu F,Lewis JT,Douglas DN,Kneteman NM,Lai R

    更新日期:2015-07-16 00:00:00

  • Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.

    abstract::Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease defined by transcriptional classifications, specific signaling and survival pathways, and multiple low-frequency genetic alterations. Preclinical model systems that capture the genetic and functional heterogeneity of DLBCL are urgently needed. Here, we g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672352

    authors: Chapuy B,Cheng H,Watahiki A,Ducar MD,Tan Y,Chen L,Roemer MG,Ouyang J,Christie AL,Zhang L,Gusenleitner D,Abo RP,Farinha P,von Bonin F,Thorner AR,Sun HH,Gascoyne RD,Pinkus GS,van Hummelen P,Wulf GG,Aster JC,Weinst

    更新日期:2016-05-05 00:00:00

  • Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

    abstract::Targeting cancer stem cells is of paramount importance in successfully preventing cancer relapse. Recently, in silico screening of public gene-expression datasets identified cyclooxygenase-derived cyclopentenone prostaglandins (CyPGs) as likely agents to target malignant stem cells. We show here that Δ(12)-PGJ(3), a n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-317750

    authors: Hegde S,Kaushal N,Ravindra KC,Chiaro C,Hafer KT,Gandhi UH,Thompson JT,van den Heuvel JP,Kennett MJ,Hankey P,Paulson RF,Prabhu KS

    更新日期:2011-12-22 00:00:00

  • Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.

    abstract::Hematopoietic stem cell transplantation from unrelated donors is an effective treatment for myeloid malignancies, but its use is usually restricted to young patients without comorbidities. The development of reduced-intensity preparative regimens has allowed the extension of this form of treatment to older and medical...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-03-0855

    authors: Wong R,Giralt SA,Martin T,Couriel DR,Anagnostopoulos A,Hosing C,Andersson BS,Cano P,Shahjahan M,Ippoliti C,Estey EH,McMannis J,Gajewski JL,Champlin RE,de Lima M

    更新日期:2003-10-15 00:00:00

  • Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.

    abstract::Approximately 60% of patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) are curable with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemoimmunotherapy. Epratuzumab (E) is an unlabeled anti-CD22 monoclonal antibody with efficacy in relapsed DLBCL. This phase 2 trial te...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-02-336990

    authors: Micallef IN,Maurer MJ,Wiseman GA,Nikcevich DA,Kurtin PJ,Cannon MW,Perez DG,Soori GS,Link BK,Habermann TM,Witzig TE

    更新日期:2011-10-13 00:00:00

  • Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

    abstract::The receptor for hyaluronic acid-mediated motility (RHAMM/CD168) has been described as a leukemia-associated antigen. To define T-cell epitopes of RHAMM/CD168 toward specific immunotherapies for acute myeloid leukemia (AML), 10 potential HLA-A2-binding RHAMM/CD168 peptides (R1 to R10) were synthesized based on compute...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4787

    authors: Greiner J,Li L,Ringhoffer M,Barth TF,Giannopoulos K,Guillaume P,Ritter G,Wiesneth M,Döhner H,Schmitt M

    更新日期:2005-08-01 00:00:00

  • MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).

    abstract::On encountering a danger signal, dendritic cells (DCs) undergo a complex maturation process and become specialized in antigen presentation. We previously reported that engagement of major histocompatibility complex (MHC) class II molecules located on immature DCs in membrane rafts by lymphocyte activation gene-3 (LAG-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0273

    authors: Andreae S,Buisson S,Triebel F

    更新日期:2003-09-15 00:00:00

  • How I treat essential thrombocythemia.

    abstract::In the past 5 years we have witnessed significant advances in both the diagnostic process and optimal therapy for patients with essential thrombocythemia (ET). Insights into the underlying molecular mechanisms have been accompanied by the development of new diagnostic tests and by an improved understanding of the rela...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-270033

    authors: Beer PA,Erber WN,Campbell PJ,Green AR

    更新日期:2011-02-03 00:00:00